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Key points
 Right ventricle (RV) function is the most important determinant of survival and quality of life
in patients with chronic thromboembolic pulmonary hypertension (CTEPH).
 The changes in right and left ventricle gene expression that contribute to ventricular
remodelling are incompletely investigated.
 RV remodelling in our CTEPH swine model is associated with increased expression of the
genes involved in inflammation (TGFβ), oxidative stress (ROCK2, NOX1 and NOX4), and
apoptosis (BCL2 and caspase-3).
 Alterations in ROCK2 expression correlated inversely with RV contractile reserve during
exercise.
 Since ROCK2 has been shown to be involved in hypertrophy, oxidative stress, fibrosis and
endothelial dysfunction, ROCK2 inhibitionmay present a viable therapeutic target in CTEPH.
Abstract Right ventricle (RV) function is the most important determinant of survival and
quality of life in patients with chronic thromboembolic pulmonary hypertension (CTEPH). The
present study investigated whether the increased cardiac afterload is associated with (i) cardiac
remodelling and hypertrophic signalling; (ii) changes in angiogenic factors and capillary density;
and (iii) inflammatory changes associated with oxidative stress and interstitial fibrosis. CTEPH
was induced in eight chronically instrumented swine by chronic nitric oxide synthase inhibition
and up to five weekly pulmonary embolizations. Nine healthy swine served as a control. After
9weeks, RV functionwas assessed by single beat analysis of RV–pulmonary artery (PA) coupling at
rest and during exercise, as well as by cardiacmagnetic resonance imaging. Subsequently, the heart
was excised and RV and left ventricle (LV) tissues were processed for molecular and histological
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analyses. Swine with CTEPH exhibited significant RV hypertrophy in response to the elevated
PA pressure. RV–PA coupling was significantly reduced, correlated inversely with pulmonary
vascular resistance and did not increase during exercise in CTEPH swine. Expression of genes
associated with hypertrophy (BNP), inflammation (TGFβ), oxidative stress (ROCK2, NOX1 and
NOX4), apoptosis (BCL2 and caspase-3) and angiogenesis (VEGFA) were increased in the RV
of CTEPH swine and correlated inversely with RV–PA coupling during exercise. In the LV, only
significant changes in ROCK2 gene-expression occurred. In conclusion, RV remodelling in our
CTEPH swine model is associated with increased expression of genes involved in inflammation
and oxidative stress, suggesting that these processes contribute toRV remodelling and dysfunction
in CTEPH and hence represent potential therapeutic targets.
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Corresponding author D. Merkus: Division of Experimental Cardiology, Department of Cardiology, Erasmus MC,
University Medical Center Rotterdam, PO Box 2040, 3000 CA Rotterdam, The Netherlands.
Email: d.merkus@erasmusmc.nl
Introduction
Chronic thromboembolic pulmonary hypertension
(CTEPH) develops in a subset of patients after acute
pulmonary embolism (Lang et al. 2016; Simonneau et al.
2017). In CTEPH, pulmonary vascular resistance, which
is initially elevated because of obstructions in the larger
pulmonary arteries, is further increased by pulmonary
microvascular remodelling (Lang et al. 2016; Simonneau
et al. 2017). This increased pulmonary vascular resistance
augments afterload of the right ventricle (RV), thereby
resulting in RV dilatation and RV hypertrophy. RV
structural and functional adaptability are important
determinants of functional capacity and survival in
patients with CTEPH (Hardziyenka et al. 2011; van
de Veerdonk et al. 2016; Claeys et al. 2018). Thus,
RV–pulmonary arterial uncoupling is associated with
reduced exercise capacity (Claeys et al. 2018) and patients
with RV dilatation have a worse prognosis compared
to patients with preserved RV function and geometry
(Blumberg et al. 2013; Grosse et al. 2018). Furthermore,
it is increasingly recognized that RV dysfunction may also
influence the left ventricle (LV), both mechanically, via
direct mechanical interaction and changes in LV filling,
by inducing interventricular asynchrony (Marcus et al.
2008; Vonk Noordegraaf et al. 2017), as well as via
activation of inflammatory pathways, which may be the
result of low grade systemic inflammation in combination
with neurohumoral activation because of reduced cardiac
output (Dell’Italia, 2011; Hardziyenka et al. 2011; Naeije
& Badagliacca, 2017).
In CTEPH, pulmonary obstructive lesions can be
located both proximally and distally. Distal pulmonary
lesions have recently been shown to be associated with
worse prognosis, in part because distal pulmonary lesions
are currently considered inoperable, and in part because
distal pulmonary emboli are associated with worse RV
function (Grosse et al. 2018). Furthermore, also in patients
with chronic thromboembolic disease, even without overt
pulmonary hypertension (PH), RV dysfunction has been
observed (McCabe et al. 2014), which is associated with
an impaired exercise capacity (Claeys et al. 2018).
The factor(s) that predispose(s) to RV failure currently
remain unknown. Unlike pulmonary arterial hyper-
tension, which is usually only detected in a very
advanced stage of the disease, CTEPH occurs mostly after
acute pulmonary embolism, which, despite the fact that
this first pulmonary embolism may also go unnoticed
(Ende-Verhaar et al, 2017), may allow earlier inter-
vention in the process of RV remodelling and adaptation.
Mild RV dysfunction is characterized by a deterioration
of RV diastolic function (i.e. relaxation), whereas RV
contraction is still preserved (McCabe et al. 2014). The
main determinant of cardiac diastolic function is cardiac
stiffness, which is negatively influenced by interstitial
fibrosis, as well as by changes in isoform expression
of the ‘cardiac spring protein’ titin (Rain et al. 2016).
Furthermore, it has been proposed that the failure of
angiogenesis to keep up with RV hypertrophy, which
results in reduced capillary densities and concommittant
RV perfusion abnormalities, is a key determinant that
discriminates between adaptive RV hypertrophy and RV
failure (Frump et al. 2018).
We have recently developed a swine model, in which
a combination of endothelial dysfunction by nitric oxide
synthase (NOS) inhibitionwith pulmonary embolizations
withmicrospheres of700 µm in diameter resulted in the
development of CTEPH with distal pulmonary micro-
vascular remodelling (Stam et al. 2018a,b). In CTEPH
animals, the increased afterload was accompanied by
RV hypertrophy, which resulted in preservation of RV
function at rest, although stroke volume (SV) decreased
with increasing exercise intensity, suggesting mild RV
dysfunction (Stam et al. 2018a).
In the present study, we investigated the changes in RV
and LV geometry and morphology in CTEPH, as well as
the concomittant changes in gene expression that may
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contribute to these changes. Specifically, we investigated
whether the increased RV afterload is associated with
(i) cardiac remodelling and hypertrophic signalling; (ii)
changes in angiogenic factors and capillary density; and
(iii) inflammatory changes associatedwith oxidative stress
and interstitial fibrosis.
Methods
Ethical approval
Animal studies were performed following the ‘Guiding
Principles for the Care and Use of Laboratory Animals’
as approved by the Council of the American Physiological
Society, and with approval of the Animal Care Committee
of the Erasmus University Medical Center (EMC3158,
109-13-09). The authors understand the ethical principles
under whichThe Journal of Physiology operates and hereby
declare that this work complies with the journal’s animal
ethics checklist (Grundy, 2015). Twenty-three crossbred
Landrace × Yorkshire swine of either sex obtained from a
commercial breeder (3 months old, weighing 22 ± 1 kg)
entered the study. Swine were individually housed in
the animal facility of the Erasmus University Medical
Center, fed twice a day and had free access to drinking
water. Our experimental protocol consists of a chronic
instrumentation, followed by induction of CTEPH in
12 animals via a combination of NOS-inhibition with
L-Nω-nitroarginine methyl ester (L-NAME) and up to
fiveweekly repeated embolizations withmicrospheres (see
below for details). Mortality as a result of acute cardio-
pulmonary failure upon CTEPH induction occurred in
two animals. Two animals were excluded because of
catheter failure (one control, one CTEPH), whereas two
animals (one control, one CTEPH) had to be killed
following repeated infections because of the catheters
and were not included. Only animals that completed the
protocol are included in the reported numbers (n).
Chronic instrumentation
Animals were chronically instrumented as described pre-
viously (De Wijs-Meijler et al. 2016; Stam et al. 2018a).
In short, after an overnight fast, swine were sedated with
an I.M. injection of tiletamine/zolazepam (5 mg kg−1),
xylazine (2.25 mg kg−1) and atropine (1 mg), intubated
and ventilated with a mixture of O2 and N2 (1:2 v/v)
to which 2% (v/v) isoflurane was added to maintain
anaesthesia. Under sterile conditions, a left thoracotomy
in the fourth intercostal space was performed, the peri-
cardium was opened and fluid-filled polyvinylchloride
catheters (Braun Medical Inc., Bethlehem, PA, USA)
were placed in the RV, pulmonary artery and aorta for
blood pressure measurement. A flow probe (Transonic
Systems Inc., Ithaca, NY, USA) was positioned around the
ascending aorta for measurement of cardiac output (CO).
The catheters were tunnelled to the back, the chest was
closed, and animals were allowed to recover for 1 week,
receiving analgesia (0.015 mg kg−1 buprenorphine I.M.
and a slow-release fentanyl patch 12 µg h−1 for 48 h) on
the day of the surgery and daily I.V. antibiotic prophylaxis
(25 mg kg−1 amoxicillin) for 7 days (DeWijs-Meijler et al.
2016).
CTEPH induction
Following the recovery week, CTEPH was successfully
induced in eight animals (four males, four females) as
described previously (Stam et al. 2018a,b). In short, on
the first day, the animals were given the NOS-inhibitor
L-NAME (10mg kg−1 I.V.; Enzo Life Sciences International
Inc, NY, USA) as a bolus infusion. On subsequent days,
the dose of L-NAME was increased by 10 mg kg−1 per day
up to 30 mg kg−1 I.V., which was maintained until 1 week
before the end of the study (Rees et al. 1990; Matsunaga
et al. 2000). L-NAME exhibits Ki values of 15 nM, 39 nM
and 4.4 µM for neuronal NOS (bovine), endothelial nitric
oxide synthase (eNOS) (human) and inducible NOS
(mouse) (Buckner et al. 1988; Furfine et al. 1993; Garvey
et al. 1994). Four days after the beginning of L-NAME
administration, microsphere infusions were started. Poly-
ethylene microspheres (diameter 600–710 µm, density
1.13 g cm−3, 500 mg, corresponding to 2500 micro-
spheres; Cospheric LLC, Santa Barbara, California, USA)
were suspended in 50 mL of autologous blood with
2500 IU. heparin and slowly infused into the RV while
monitoring mean pulmonary artery pressure (mPAP).
Microsphere infusions were repeated until the mPAP
reached 60 mmHg, or the arterial PaO2 dropped below
40 mmHg, as measured at rest 30 min after infusion,
or when a maximum of 3 g (15000) microspheres
was infused on 1 day based on the assumption that
the porcine lungs contain 25000 small arteries of this
diameter. In the subsequent 4weeks, haemodynamicswere
assessed weekly, and microsphere infusions were repeated
when mPAP was <25 mmHg and PaO2 >70 mmHg, as
described above. During the final 5 weeks of follow-up, no
microsphere infusions were performed, whereas L-NAME
administration was discontinued 1 week before death
(Stam et al. 2018a,b).
Seven sham-operated animals (three males, four
females), which did not receive L-NAME or microspheres,
and two additional healthy animals (two females), which
were not operated on, served as controls.
In vivo experiments
Haemodynamic studies. Haemodynamic studies were
performed 10 weeks after surgery. With swine standing
quietly on a motor-driven treadmill and during exercise
at 4 km h−1, CO, PAP, aorta pressure (AoP) and RV
pressure were recorded continuously (Duncker et al. 1998;
C© 2019 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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De Wijs-Meijler et al. 2016). Two animals were unable to
perform exercise testing.
Digital recording and offline analysis of haemodynamic
data were performed as described previously (Duncker
et al. 1998; Stubenitsky et al. 1998). To account for
differences in growth between animals, CO was corrected
for body weight, yielding cardiac index (CI). Stroke
volume index (SVi) was calculated as CI/heart rate.
Total pulmonary vascular resistance index (tPVRi) and
systemic vascular resistance index (SVRi) were calculated
as mPAP/CI and mAoP/CI, respectively. RV function
was measured by single beat analysis of RV–pulmonary
artery (PA) coupling as described previously (Brimioulle
et al. 2003), using the median value of at least 10
consecutive beats, assuming that end-systolic PAP equals
mPAP (Chemla et al. 1996; Brimioulle et al. 2003).
For calculation of Ees, a sine wave was fitted to the
isovolumetric contraction and relaxation phases of RV
contraction. The top of the sine wave has previously been
shown to be a good approximation of Pmax, derived from
isovolumetric contraction (Fig. 1). Ees was subsequently
calculated as (Pmax – mPAP)/SVi. Ea was calculated as
mPAP/SVi. RV–PA coupling was assessed as the ratio of
Ees and Ea.
Cardiovascular magnetic resonance imaging. After
completion of the haemodynamic experiments, a cardio-
vascular magnetic resonance (CMR) examination was
performed on a 1.5 T clinical scanner with a dedicated
32-channel phased-array cardiac surface coil (Discovery
MR450; GE Healthcare, Milwaukee, WI, US, USA) in
five control (two male, three female) and six CTEPH
(four male, two female) animals. For this purpose,
animals were sedated and intubated as described above.
During imaging, anaesthesia was maintained with pento-
barbital sodium (6–12 mg kg−1 h−1 I.V.). Mechanical
ventilation and breath-holds were performed using a
mobile ventilator (CarinaTM; Dra¨ger Medical, Best, The
Netherlands). When necessary, and always in absence
of pain reflexes, muscle relaxation was temporarily
achieved using pancuronium bromide (2–4 mg I.V.
bolus). The imaging protocol consisted of retrospectively
ECG-gated balanced Steady-State Free Precession cine
imaging with breath-holding (FIESTA; GE Medical
Systems, Waukesha, WI, USA). Standard long-axis and
short-axis images with full LV and RV coverage were
obtained. Typical scan parameters were slice thickness
6.0 mm, slice gap 0 mm, TR/TE 3.4/1.4 ms, flip angle
75°, field of view 320 × 240 mm, acquired matrix
180 × 128 and reconstructed matrix 256 × 256. To
assess dimensions, function and mass of both ventricles,
LV and RV epi- and endocardial contours were drawn
manually on end-diastolic and end-systolic short axis cine
images. Volumes and masses were measured, and stroke
volumes and ejection fractions (EF) were calculated.
All volumes were indexed for body weight. QMassMR
analytical software, version 8.1 (Medis BV, Leiden, The
Netherlands) was used for analysis.
Euthanasia
After completion of the in vivo experiments, with animals
intubated and under deep anaesthesia (pentobarbital
sodium, 6–12 mg kg−1 h−1 I.V.), a sternotomy was
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Figure 1. Typical example of RV–PA coupling analysis
showing haemodynamic signals (three beats) and their
derivatives
Pmax was determined as the maximal value from a sine-fit of RV
pressure (RVP), Pes was estimated to equal mPAP, whereas SV was
calculated as the time-integral of aorta flow (AoF).
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performed, ventricular fibrillation was induced using a
9 V battery and the heart was immediately excised. To
assess relative RV hypertrophy, the heart was sectioned
into RV free wall and LV (including septum) and then
weighed. RV hypertrophy was assessed using the Fulton
index (RV/LV). Parts of the LV anterior wall and RV were
snap frozen in liquid nitrogen within 10min after excision
for molecular analyses and fixated in formaldehyde for
histological analysis.
Histology
LV and RV tissues were fixated in 3.5–4% buffered
formaldehyde for a minimum of 24 h and embedded
in paraffin wax. Subsequently, 5 µm sections were
cut and stained with (i) Gomori to assess cardio-
myocyte cross-section area (CSA); (ii) lectin to assess
capillary density; and (iii) Picrosirius red to assess
collagen content (Sorop et al. 2018). The stained
sections were scanned using a Hamamatsu NDP scanner
(Hamamatsu Nanozoomer 2.0 HT; Hamamatsu Photo-
nics KK, Hamamatsu City, Japan). Morphometric
measurements of CSA and capillary density (expressed
as number of capillaries per mm2 and per cardiomyocyte)
were performed using Clemex Vision Professional Edition
(Clemex Technologies Inc., Corporate Headquarters,
Quebec, Canada), whereas collagen content was analysed
using BioPixiQ (BioPix AB, Gothenburg, Sweden) as
described previously (Sorop et al. 2018).
Real-time quantitative PCR
Total RNA was extracted from snap frozen LV and
RV tissues with a RNeasy Fibrous Tissue Mini Kit
(Qiagen, Venlo, The Netherlands) as described pre-
viously (Stam et al. 2018a). RNA integrity was confirmed
using a Bioanalyzer (2100 Bioanalyzer; Agilent, Santa
Clara, CA, USA). cDNA was synthesized from 500 ng
of total RNA with a SensiFAST cDNA Synthesis Kit
(Bioline, London, UK). A quantitative RT-PCR (CFX-96;
Bio-Rad, Hercules, California, USA) was performed with
a SensiFAST SYBR & Fluorescein Kit (Bioline). Target
genes mRNA expression levels were normalized against
β-actin, glyceraldehyde-3-phosphate dehydrogenase and
cyclophilin using the Ct method with the gene study
function in CFX manager software (Bio-Rad). All primer
sequences are presented in Table 1.
Titin isoform composition
Titin isoform protein composition (i.e. presence of the
stiff N2B and compliant N2BA isoforms) was analysed
as described previously (Sorop et al. 2018). In short,
snap frozen LV and RV tissues were weighed and
pulverized in liquid nitrogen using a mortar and pestle.
Cardiac tissue powder was solubilized in 8 mol L−1
urea buffer with dithiothreitol and 50% glycerol solution
with protease inhibitors (4 × leupeptin, E-64 and
phenylmethanesulphonyl fluoride). Equal dilutions were
calculated based on myosin heavy chain content and
homogenate samples were loaded on custom-made 1%
agarose gels. Gels were stainedwith SYPRORuby. Samples
were measured in triplicate. Only samples with 20%
degradation were used. Titin isoforms N2B and N2BA
were normalized to the total titin amount and the
N2B/N2BA ratio was calculated.
Statistical analysis
SPSS, version 21.0 (IBM Corp., Armonk, NY, USA) was
used for the statistical analysis. Statistical analysis was
performed with a mixed model ANOVA, with exercise
as a repeated measure and CTEPH as a between group
comparison, and exercise×CTEPHas an interaction term
for the analysis of haemodynamics. ANOVA with CTEPH
as a factor was performed for the MRI data, histology
and gene expression. Bonferroni post hoc testing was
performed when appropriate. The correlation coefficient
r2 was calculated for the relations between two continuous
variables. P< 0.05 was considered statistically significant.
Data are presented in box and whisker plots with the
whiskers reflecting minimum to maximum and the
median presented as a line.
Results
Cardiac hypertrophy and function
CTEPH resulted in an increased RV afterload, as indicated
by an increase in mPAP, tPVRi and Ea (Fig. 2). This
sustained increase in afterload resulted an increase in
RV-BNP expression (Table 2), suggestive of increased RV
wall stress. Indeed, trends towardsRVdilatation (P= 0.15)
and decreased EF (P = 0.08) as measured with CMR
were observed (Fig. 3). However, end-systolic elastance
(Ees), an index of RV contractility, was higher in CTEPH,
whereas RV dP/dtmax and RV dP/dtmin were unchanged
(Fig. 2). Although RV–PA coupling was reduced, CI was
maintained in CTEPH (Fig. 2). Furthermore, heart rate,
mAoP (Table 3), LV volume, LVEF (Fig. 3) and LV-BNP
expression (Table 2) were not altered.
Exercise resulted in increases in mPAP and Ea that
were larger in CTEPH compared to control, whereas the
exercise induced increase in CI was blunted. Moreover,
although Ees increased in both CTEPH and control
animals, Ees was no longer different between groups.
Hence, RV–PA coupling, which increased with exercise
in the control swine, did not change significantly during
C© 2019 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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Table 1. Primer sequences used for the quantitative PCR
Sequence
Genes Forward Reverse
β-actin TCCCTGGAGAAGAGCTACGA AGCACCGTGTTGGCGTAGAG
Cyclophilin AGACAGCAGAAAACTTCCGTG AAGATGCCAGGACCCGTATG
GAPDH GCTCATTTCCTCGTACGAC GAGGGCCTCTCTCCTC
α-SMA GGACCCTGTGAAGCACCAG GGGCAACACGAAGCTCATTG
β-MHC AGATGAACGAGCATCGGAGC TACTGTTCCCGAAGCAGGTCAG
ANP TGAACCCAGCCCAGAGAGAT CAGTCCACTCTGTGCTCCAA
BNP CAAGTCCTCCGGGGAATACG TACCTCCTGAGCACATTGCAG
SERCA2a GACAATGGCGCTGTCTGTTC ATCGGTACATGCCGAGAACG
PLN TTCCAGCTAAACACCGATAAGA AGGCAGCCTTGGCTGTTTAT
BCL2 GATAACGGAGGCTGGGATGC TTATGGCCCAGATAGGCACC
BCLXL TGAGTCGGATCGCAACTTGG GCTAGAGTCATGCCCGTCAG
Casp3 GCTGCAAATCTCAGGGAGAC CATGGCTTAGAAGCACGCAA
eNOS GGACACACGGCTAGAAGAGC TCCGTTTGGGGCTGAAGATG
VEGFA ACTGAGGAGTTCAACATCGCC CATTTACACGTCTGCGGATCTT
HIF1α TTTACTCATCCGTGCGACCA AGCTCCGCTGTGTATTTTGC
HIF2α GTCGAAGATCAGCACACGGA CACCGCTCCTGAGACTCTTC
IL-6 CTCCAGAAAGAGTATGAGAGC AGCAGGCCGGCATTTGTGGTG
TNF-α TGCACTTCGAGGTTATCGGCC CCCACTCTGCCATTGGAGCTG
IFN-γ GAAGAATTGGAAAGAGGAGAGTGAC TGCTCCTTTGAATGGCCTGG
TGF-β1 GTGGAAAGCGGCAACCAAAT CACTGAGGCGAAAACCCTCT
BMPR2 GGATGCTGACAGGAGATCGT CTGGCGGTTTGCAAAGGAAA
PAI-1 TGAATGAGAGCGGCACGGTG TTGTGCCGCACCACGAACAG
Id-1 GGAGTTGGAGCTGAACTCGG GCGATCGTCCGCTGGAACAC
NOX1 CCATTCATATTCGAGCAGCAGG AACATCCTCACTGACAGTGCC
NOX2 TTGGCGATCTCAGCAGAAGG GAGGTCAGGGTGAAAGGGTG
NOX4 GCAGACTTACTCTGTGTGTTG CCATCTGTCTGACTGAGGTAC
PCNA GAACCTCACCAGCATGTCCAA TAGTGCCAAGGTGTCTGCAT
RhoA AGGGAGAAGAACACTTCCGC GGGCATCTTGTGTTTCCACC
ROCK1 AGGACCAATTCCCGGAGGTA AGCCAACTCTACCTGCTTTCC
ROCK2 ATCAAACGATATGGCTGGAAG CCATAGACGGATTGGATTGTTCC
MMP2 AGGACATCAGCGGTAAGACC GGTAGAGGTAGACCAGCGGA
MMP9 TCGACGTGAAGACGCAGAAG ACCTGATTCACCTCGTTCCG
TIMP1 GATCTATGCTGCTGGCTGTGA GTCTGTCCACAAGCAGTGAGT
TIMP2 TTGCAATGCAGACGTAGTGA GCCTTTCCTGCGATGAGGT
TIMP3 ACGCCTTCTGCAACTCTGAC AGCCTCGGTACATCTTCATCT
Col1 AGACATCCCACCAGTCACCT TCACGTCATCGCACAACACA
Col2 CTTGAGACTCAGCCACCCAG CCGAATGCAGGTTTCACCAG
Col3 AATCATGCCCTACTGGTGGC CGGGTCCAACTTCACCCTTA
GAPDH, glyceraldehyde-3-phosphate dehydrogenase; α-SMA, α-smooth muscle actin; β-MHC, β-myosin heavy chain; ANP,
atrial natriuretic peptide; BNP, brain natriuretic peptide; SERCA2a, sarcoplasmic/endoplasmic reticulum Ca(2+)ATPase 2a; PLN,
phospholamban; BCL2, B-cell lymphoma 2; BCLXL, B-cell lymphoma-extra large; Casp3, caspase 3; eNOS, endothelial nitric oxide
synthase; VEGFA, vascular endothelial growth factor-A; HIF1α, hypoxia inducible factor 1α; HIF2α, hypoxia inducible factor 2α;
IL-6, interleukin-6; TNF-α, tumour necrosis factor α; IFN-γ, interferon-γ; TGF-β1, transforming growth factor β1; BMPR2, bone
morphogenetic protein receptor 2; PAI-1, Plasminogen activator inhibitor-1; Id-1, inhibitor of DNA binding; NOX1, NADPH oxidase
1; NOX2, NADPH oxidase 2; NOX4, NADPH oxidase 4; PCNA, Proliferating cell nuclear antigen; RhoA, Ras homologue gene family
member A; ROCK1, rho-associated, coiled-coil-containing protein kinase 1; ROCK2, Rho associated coiled-coil containing protein
kinase 2; MMP2, matrix metalloproteinase-2; MMP9, matrix metalloproteinase-9; TIMP1, tissue inhibitor of metalloproteinases 1;
TIMP2, tissue inhibitor of metalloproteinases 2; TIMP3, tissue inhibitor of metalloproteinases 3; Col1, collagen type 1; Col2, collagen
type 2; Col3, collagen type 3.
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exercise in CTEPH animals (Fig. 2). Indeed, RV–PA
coupling worsened with exercise in four out of six CTEPH
animals, and correlated inversely with tPVRi (Fig. 4).
Moreover, the CTEPH animal with the worst RV function
was uncapable of performing exercise at 4 km h−1 as a
result of RV failure, as indicated by a significant reduction
in mAoP during exercise (animal not included in Fig. 4).
Altogether, these data are consistent with RV dysfunction
that is still compensated for at rest but is excacerbated
during exercise.
As reportedpreviously (Stam et al. 2018a), the increased
RV afterload resulted in RV hypertrophy, as indicated by
an increased RV/BW and Fulton index (Fig. 5), as well
as an increased RV cardiomyocyte CSA in CTEPH (Fig.
6). RV cardiomyocyte CSA of CTEPH animals resembled
those of LV cardiomyocytes. LV cardiomyocytes were
similar in size in LV of CTEPH compared to control
animals (Fig. 6), consistent with themaintained LVW/BW
in CTEPH compared to control swine (Fig. 5). Expression
of SERCA2a, its inhibitor phospholamban (PLN) and
their ratio did not change in the RV (Table 2). However,
there was a shift in RV titin isoform expression from the
stiff N2B to the more compliant N2BA isoform (Fig. 6).
The pro-apoptotic gene caspase-3 was up-regulated in
Figure 2. Haemodynamics at rest and during exercise after 9 weeks of CTEPH
Data obtained at rest and during maximal exercise at 4 km h−1 in control swine (n = 7) and CTEPH swine (n = 7).
A, mean pulmonary artery pressure (mPAP). B, cardiac index (CI). C, total pulmonary vascular resistance index
(tPVRi). D, arterial elastance (Ea). E, end-systolic elastance (Ees). F, RV–PA coupling (Ees/Ea). G, maximum rate of
fall of RV pressure (RV dP/dtmin). H, maximum rate of rise of RV pressure (RV dP/dtmax). I, stroke work at rest
and during exercise. Whiskers denote minimum to maximum and the median is indicated by the line. ∗P < 0.05,
(∗)P < 0.1 CTEPH vs. corresponding control; †P < 0.05, (†)P < 0.1 Exercise vs. corresponding rest; ‡P < 0.05,
(‡)P < 0.1 Exercise × CTEPH (i.e. effect of exercise on variable is different in CTEPH from control).
C© 2019 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
8 K. Stam and others J Physiol 00.0
Table 2. Relative gene expression in control and CTEPH left and right ventricle tissue
LV RV
control n CTEPH n P value control n CTEPH n P value
Hypertrophy and
contractility
α-SMA 0.36 ± 0.03 9 0.39 ± 0.08 6 0.72 0.17 ± 0.04 9 0.45 ± 0.23 5 0.14
β-MHC 1.06 ± 0.08 9 0.94 ± 0.14 6 0.43 1.02 ± 0.07 9 1.10 ± 0.10 5 0.50
ANP 0.34 ± 0.07 8 0.29 ± 0.07 6 0.65 0.81 ± 0.18 9 0.45 ± 0.14 5 0.20
BNP 0.11 ± 0.03 9 0.22 ± 0.07 6 0.12 0.12 ± 0.06 9 0.90 ± 0.23 5 0.001
SERCA2a 1.05 ± 0.09 9 1.08 ± 0.12 6 0.88 0.77 ± 0.10 9 0.78 ± 0.25 5 0.97
PLN 1.40 ± 0.07 9 1.28 ± 0.10 6 0.30 1.32 ± 0.13 9 1.26 ± 0.12 5 0.76
PLN/SERCA2a 1.39 ± 0.12 9 1.21 ± 0.06 6 0.25 1.87 ± 0.19 9 1.95 ± 0.29 5 0.81
Apoptosis BCL2 0.57 ± 0.04 9 0.72 ± 0.09 6 0.10 0.86 ± 0.06 9 1.16 ± 0.12 5 0.03
BCLXL 0.74 ± 0.08 9 0.62 ± 0.15 6 0.48 1.07 ± 0.10 9 0.87 ± 0.13 5 0.26
Casp3 0.74 ± 0.06 9 0.70 ± 0.06 6 0.64 0.88 ± 0.05 9 1.22 ± 0.16 5 0.03
Endothelial function
and angiogenesis
eNOS 0.94 ± 0.06 9 0.87 ± 0.13 6 0.61 0.77 ± 0.05 9 0.81 ± 0.06 5 0.56
VEGFA 1.16 ± 0.12 9 1.36 ± 0.14 6 0.31 0.93 ± 0.09 9 1.25 ± 0.14 5 0.07
HIF1α 1.19 ± 0.03 9 1.14 ± 0.12 6 0.61 1.14 ± 0.04 9 1.06 ± 0.05 5 0.20
HIF2α 1.00 ± 0.02 9 0.91 ± 0.11 6 0.35 1.20 ± 0.10 9 1.16 ± 0.12 5 0.81
Inflammation IL-6 0.24 ± 0.06 9 0.90 ± 0.57 6 0.19 0.09 ± 0.04 9 0.31 ± 0.25 5 0.26
TNF-α 0.22 ± 0.06 9 0.31 ± 0.11 6 0.46 0.27 ± 0.04 9 0.35 ± 0.12 5 0.40
IFN-γ 0.84 ± 0.20 9 0.48 ± 0.13 6 0.20 0.44 ± 0.09 9 0.31 ± 0.06 5 0.33
TGF-β and BMP TGF-β1 0.80 ± 0.05 9 0.79 ± 0.04 6 0.92 0.81 ± 0.02 9 0.91 ± 0.06 5 0.08
BMPR2 0.92 ± 0.09 9 0.79 ± 0.09 6 0.35 1.04 ± 0.05 9 1.15 ± 0.06 5 0.22
PAI-1 0.38 ± 0.05 9 0.46 ± 0.09 6 0.42 0.23 ± 0.08 9 0.48 ± 0.14 5 0.10
Id-1 0.49 ± 0.05 9 0.47 ± 0.12 6 0.92 0.61 ± 0.09 9 0.75 ± 0.20 5 0.50
Oxidative stress NOX1 1.11 ± 0.26 9 1.33 ± 0.42 6 0.64 0.71 ± 0.13 9 1.20 ± 0.17 5 0.04
NOX2 0.45 ± 0.04 9 0.61 ± 0.09 6 0.08 0.63 ± 0.09 9 0.68 ± 0.11 5 0.70
NOX4 0.97 ± 0.08 9 1.13 ± 0.09 6 0.24 0.70 ± 0.06 9 1.03 ± 0.15 5 0.03
PCNA 0.95 ± 0.07 9 0.82 ± 0.07 6 0.25 1.04 ± 0.09 9 1.10 ± 0.22 5 0.79
RhoA 1.13 ± 0.22 9 1.13 ± 0.03 6 0.72 1.12 ± 0.04 9 1.05 ± 0.06 5 0.36
ROCK1 1.23 ± 0.05 9 1.22 ± 0.04 6 0.91 1.06 ± 0.06 9 1.11 ± 0.11 5 0.62
ROCK2 0.76 ± 0.05 9 0.93 ± 0.06 6 0.05 0.61 ± 0.04 9 0.95 ± 0.11 5 0.004
Extracellular matrix
and fibrosis
MMP2 1.30 ± 0.18 6 1.65 ± 0.49 4 0.46 0.89 ± 0.13 9 0.72 ± 0.05 5 0.38
MMP9 0.89 ± 0.23 9 1.27 ± 0.49 6 0.45 0.61 ± 0.16 8 0.58 ± 0.06 4 0.89
TIMP1 0.65 ± 0.11 9 0.65 ± 0.11 6 0.75 0.69 ± 0.14 9 0.78 ± 0.13 5 0.69
TIMP1/MMP9 1.13 ± 0.25 9 0.90 ± 0.28 6 0.56 1.79 ± 0.40 8 1.49 ± 0.43 4 0.65
TIMP2 1.03 ± 0.10 9 1.24 ± 0.22 6 0.35 0.89 ± 0.12 9 0.95 ± 0.08 5 0.74
TIMP2/MMP2 0.90 ± 0.12 6 0.84 ± 0.05 4 0.69 1.04 ± 0.05 9 1.35 ± 0.12 5 0.02
TIMP3 1.27 ± 0.08 9 1.08 ± 0.06 6 0.12 0.79 ± 0.05 9 0.76 ± 0.08 5 0.75
Col1 0.94 ± 0.14 9 1.11 ± 0.50 6 0.70 0.56 ± 0.16 9 0.44 ± 0.17 5 0.63
Col2 0.85 ± 0.15 9 1.12 ± 0.49 6 0.54 0.65 ± 0.15 9 0.46 ± 0.15 5 0.42
Col3 0.95 ± 0.14 9 1.13 ± 0.50 6 0.70 0.73 ± 0.16 9 0.43 ± 0.12 5 0.24
Col1/3 0.99 ± 0.05 9 0.98 ± 0.03 6 0.88 0.75 ± 0.06 9 0.95 ± 0.09 5 0.09
Relative gene expression of right and left ventricle tissue obtained from control and CTEPH swine. For abbreviations, see Table 1. Data
are mean ± SEM. Bold italic values indicate P < 0.05, italic values indicate P < 0.10
the RV, whereas the anti-apoptotic gene BCL2 was also
up-regulated in the RV of CTEPH animals (Table 2).
Expression of BCL2 correlated modestly and inversely
with RV–PA coupling during exercise (Fig. 7) but not
with resting RV–PA coupling (r2 = 0.08; not shown). In
the LV, none of the genes involved in cardiac hypertrophy
and apoptosis were significantly affected in CTEPH
animals.
Angiogenesis
We observed an increase in capillary density in the
RV of swine with CTEPH compared to control (Fig.
6), which correlated with the increased stroke work
(Fig. 6) and was consistent with the trend towards
increased VEGFA expression (Table 2). Moreover, VEGFA
expression correlated inversely with RV–PA coupling
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during exercise (Fig. 7) but not with resting RV–PA
coupling (r2 = 0.34; not shown). By contrast, no changes
in capillary density or VEGFA expression were observed
in the LV.
Inflammation, oxidative stress and interstitial fibrosis
Although expression of the immunomodulatory genes
TNF-α, IL-6 and IFN-γ was not altered in the RV,
TGF-β1 gene expression tended to be higher in the RV of
CTEPH swine, whereas BMPRII was not altered (Table 2).
Consistent with a perturbation in the TGF-β–BMP
balance, PAI also tended to be increased, whereas Id-1 did
not change (Table 2).This shift in theTGF-β–BMPbalance
was accompanied by an increased expression of ROCK2,
NOX-1 and NOX-4 in the RV (Table 2), indicative of an
increase in oxidative stress. Expression of ROCK2, NOX-1
and NOX-4 correlated inversely with RV–PA coupling
during exercise (Fig. 7) but not with resting RV–PA
coupling (r2 = 0.29, 0.01 and 0.16 for ROCK2, NOX1 and
NOX4, respectively).
These changes in gene expression of pro-inflammatory
genes and genes promoting oxidative stress did not result
in overt changes in interstitial fibrosis because collagen
content was similar in the RV of CTEPH vs. control swine
(Fig. 6). Although no change in interstitial fibrosis was
Figure 3. RV and LV dimensions and function measured by
CMR imaging
A, end-diastolic volume index (EDVi). B, end-systolic volume index
(ESVi). C, stroke volume index (SVi). D, ejection fraction (EF).
Whiskers denote minimum to maximum and the median is indicated
by the line. Control, n = 5; CTEPH, n = 6. (∗)P < 0.1 CTEPH vs.
control.
Table 3. Systemic haemodynamics at rest and during exercise
Control CTEPH
BW Instrumentation 20 ± 1 23 ± 1
End of study 61 ± 2 62 ± 3
HR Rest 136 ± 21 131 ± 4
Exercise 235 ± 15† 211 ± 8†‡
SVi Rest 1.28 ± 0.09 1.17 ± 0.17
Exercise 1.07 ± 0.09† 0.99 ± 0.13
mAoP Rest 91 ± 4 100 ± 4
Exercise 96 ± 4(†) 116 ± 4∗†(‡)
SVRi Rest 561 ± 24 839 ± 205
Exercise 384 ± 25† 752 ± 252
Body weight (BW) and systemic haemodynamic data at rest and
during exercise. HR, heart rate; SVi, stroke volume index; mAoP,
mean aorta pressure; SVRi, systemic vascular resistance index.
Data are mean ± SEM. Control n = 7, CTEPH n = 7. ∗P < 0.05
CTEPH vs. corresponding control; †P < 0.05, (†)P < 0.1 Exercise
vs. corresponding rest; ‡P < 0.05, (‡)P < 0.1 Exercise × CTEPH (i.e.
effect of exercise on variable is different in CTEPH from control).
observed, there was a trend towards a shift in expression of
Col3 to the stiffer Col1 isoform, which was accompanied
by an increase in the ratio of TIMP2/MMP2 (Table 2)
that correlated inversely with RV–PA coupling (Fig. 7),
suggesting reduced ECM turnover in the diseased RV.
With the exception of an increase in ROCK2 and a
trend towards an increase inNOX2 expression, no changes
Figure 4. Correlation between total pulmonary vascular
resistance (tPVRi) and RV–PA coupling
Correlation between total pulmonary vascular resistance (tPVRi) and
RV–PA coupling during maximal exercise at 4 km h−1 in control
swine (n = 7) and CTEPH swine (n = 6). The P value denotes the
significance of the slope from zero.
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in genes involved in inflammation, oxidative stress and
fibrosis were observed in the LV (Table 2), which is
consistent with the absence of changes in LV myocardial
interstitial collagen content.
Discussion
The present study investigated functional, histological
and molecular changes in the RV and LV in swine with
CTEPH. The main findings were that CTEPH resulted in
(i) RV hypertrophy, both at the global and the myocyte
level; (ii) mild RV dysfunction, as indicated by decreased
RV–PAcoupling and elevatedBNPexpression,with trends
towards an increased RV EDVi and a lower EF; (iii) a
further decrease in RV–PA coupling during exercise that
correlated with an increase in ROCK2, NOX1 and NOX4
expression; and (iv) increased VEGFA expression that was
accompanied by an increased capillary density in the RV.
Finally, CTEPH did not result in changes in LV structure
or function and was associated with minor changes in LV
gene expression in our swine model.
Animal model
CTEPH was induced in juvenile swine by first inducing
endothelial dysfunction through chronic NOS-inhibition,
followed by up to five repeated embolizations with micro-
spheres. We previously showed that this combination
was required because neither NOS-inhibition, nor
embolization alone were sufficient to induce chronically
elevated pulmonary artery pressures, whereas the
combination of NOS-inhibition and embolization
resulted in a progressive increase in tPVRi that
continued to increase after the last embolization and was
accompanied by pulmonary microvascular remodelling
(Stam et al. 2018a,b). The required induction of end-
othelial dysfunction may be the result of the younger
age of our animals because endothelial NO-production
decreases with age (Liu et al. 1992; Parker et al. 2000).
Also in humans, endothelial dysfunction is often pre-
sent both in patients with acute pulmonary embolism, as
well as with CTEPH, and correlates with disease severity
(Reesink et al. 2006; In et al. 2016; Chibana et al. 2017). In
humans, CTEPH prevalence is higher in females (Kirson
et al. 2011), although male patients typically have a worse
prognosis (Chen et al. 2018). In the present study, male
and female swine were used because we have previously
shown that there are subtle differences in regulation
of pulmonary vascular tone (de Beer et al. 2010; de
Wijs-Meijler et al. 2017) and hence it is possible that
sex also affects development of CTEPH and subsequent
RV remodelling in our animals. Unfortunately, the small
group size precludes statistical assessment of the effect of
sex.
RV function and remodelling
RV afterload increases during development and
progression of pulmonary hypertension. To cope with
the increased afterload, the RV undergoes structural
and functional changes to augment contractility,
and there is evidence that this RV structural and
functional adaptability are important determinants of
functional capacity and survival in patients with CTEPH
(Hardziyenka et al. 2011; van de Veerdonk et al. 2016;
Claeys et al. 2018). The effects of CTEPH on cardiac
structure, function and gene expression were therefore
examined in our porcine model. CTEPH resulted in
an increase in RV cardiomyocyte size and global RV
hypertrophy, which was accompanied by activation of
both pro- and anti-apoptotic gene expression (increases
in caspase-3 and BCL2, respectively). Although these
Figure 5. Cardiac hypertrophy
(A) Fulton index calculated as the ratio of right ventricular weight (RVW) and left ventricular weight (LVW) and
(B) RVW over body weight (BW) were increased at death in CTEPH swine, whereas (C) LVW over BW was similar
in CTEPH and control swine. Whiskers denote minimum to maximum and the median is indicated by the line.
Control, n = 9; CTEPH, n = 8. ∗P < 0.05 CTEPH vs. control.
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data suggest that apoptosis is probably altered in the
remodeled RV, apoptosis is determined by enzyme activity
rather than expression. Future experiments examining
activity of enzymes involved in apoptosis and TUNEL
(terminal deoxynucleotidyl transferase dUTP nick end
labelling) staining should be performed to clarify whether
the increased mRNA expression is indeed translated to
alterations in apoptosis.
Consistent with our previous study in which RV
dimensions were assessed using echocardiography in
awake swine (Stam et al. 2018a), CTEPH resulted in
trends towards RV dilatation and a reduced RVEF. In
the present study, RV resting function was still pre-
served, as indicated by a maintained CI, although BNP
expression was increased, suggestive of an increased wall
stress (Torbicki & Fijałkowska, 2007). These findings are
consistent with observations in another porcine CTEPH
model, in which CTEPH is induced by ligation of the left
pulmonary artery, in combination with embolization of
the proximal segmental arteries with glue (Guihaire et al.
2013, 2014, 2015). In that model, RV dilatation (Guihaire
et al. 2015) and RV myocyte hypertrophy (Guihaire
et al. 2014) were also accompanied by an increased BNP
expression (Guihaire et al. 2014, 2015), which correlated
inversely with stroke volume and positively with global
RV hypertrophy (Guihaire et al. 2014). Furthermore,
RV–PA coupling, an index of how well the RV can cope
with the increased afterload, was reduced in that study
and a correlation was found between reduced coupling
and a reduced SV reserve with dobutamine (Guihaire
et al. 2015). Similarly, in the present study, severity of
CTEPH, as reflected in the tPVRi, correlated inversely
Figure 6. Histological analyses in control and CTEPH animals of both the left ventricle (LV) and right
ventricle (RV)
A, capillary density per mm2 (lectin staining). B, capillary–fiber ratio. C, correlation between stroke work during
maximal exercise at 4 km h−1and RV capillary–fiber ratio. D, interstitial fibrosis [picrosirius red (PSR) staining].
E, cardiomyocyte size. F, cardiomyocyte size normalized for body weight (Gomori staining, CSA). Myofilament
composition in terms of the two different titin isoforms. G, N2BA (N2BA/Titin). H, N2B (N2B/Titin). I, ratio of N2BA
and N2B. Whiskers denote minimum to maximum and the median is presented by the line. Control, n = 8; CTEPH,
n = 6. ∗P < 0.05 CTEPH vs. control (∗)P < 0.1 CTEPH vs. control.
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with RV–PA coupling during exercise. Importantly, recent
studies inpatientswithCTEPHshow thatRV–PAcoupling
correlates with exercise capacity (Claeys et al. 2018), which
in turn is a strong prognosticator (Blumberg et al. 2013).
It is increasingly recognized that not only RV systolic
function, but also RV diastolic function correlates with
prognosis in patients with pulmonary arterial hyper-
tension (PAH) (Trip et al. 2015). Indeed, in pigs with type
II pulmonary hypertension (PH), abnormalities in RV–PA
coupling were accompanied by diastolic dysfunction
(Aguero et al. 2014). Diastolic RV chamber stiffness is
determined by myocyte stiffness, as well as interstitial
collagen. In a rat model of pulmonary artery banding,
mild RV dysfunction was accompanied by an increase
in myocyte stiffness, whereas interstitial fibrosis was
only observed in the presence of severe RV dysfunction
(Rain et al. 2016). In these rats, the increased myocyte
stiffness was accompanied by a paradoxical increase in
the more compliant titin N2BA isoform, possibly to blunt
a further increase in myocyte stiffness. Consistent with
these findings, the mild RV dysfunction in our swine with
CTEPH was accompanied by an increase in titin N2BA,
whereas no changes in myocardial collagen content were
observed histologically. Furthermore, no changes in Col1
and Col3 expression were observed, although there was
a change in the ratio between Col1 and Col3 indicating a
relatively higher expression of the stiff Col1 isoform. These
data are also consistent with the isoform shift observed by
Rain et al. (2016) andmay have contributed to a stiffer RV.
The transition from RV dysfunction to overt RV failure
is associated with inflammation and activation of the
immune response (Frangogiannis, 2017; Sun et al. 2017;
Dewachter & Dewachter, 2018). Although expression of
genes involved in immune modulation (TNF-α, IL-6,
IFN-γ) was not altered, expression of TGF-β1 tended
to be increased. Activation of the TGF-β pathway was
further confirmed by the increase in expression of
its downstream target PAI-1. Both activation of the
TGF-β pathway and increased circulating levels of end-
othelin, as previously shown to be present in our
porcine CTEPH model (Stam et al. 2018b), can result
in activation of the Rho-kinase pathway (Zeidan et al.
2014; Shimizu & Liao, 2016; Tsai et al. 2017). Indeed,
ROCK2 expression was up-regulated in CTEPH swine
and showed a strong inverse correlation with RV–PA
coupling. ROCK2 activation is involved in cardiac hyper-
trophy and oxidative stress and also plays a deleterious
role in RV remodelling (Ikeda et al. 2014; Sunamura
et al. 2018). ROCK2 phosphorylates protein phosphatase
1, which regulates both myofilament sensitivity to Ca2+,
as well as Ca2+-handling (Hartmann et al. 2015). Hence,
although SERCA2a and phospholamban gene expression
were not changed in the present study, it is possible that
post-translational modifications in their phosphorylation
Figure 7. Correlation of the RV–PA coupling during exercise
Correlation of the RV–PA coupling during exercise with expression of (A) vascular endothelial growth factor
A (VEGFA), (B) NADPH oxidase 1 (NOX1), (C) NADPH oxidase 4 (NOX4), (D) Rho-associated protein kinase 2
(ROCK2), (E) B-cell lymphoma 2 (BCL2) and (F) ratio of tissue inhibitor of metalloproteinases 2 (TIMP2) over matrix
metalloproteinase-2 (MMP2) in the RV. Control, n = 7; CTEPH, n = 4. The P value denotes significance of the
slope from zero.
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status contributed to altered Ca2+ handling. Indeed, it
has been suggested that changes in Ca2+-handling may
play a role in the development of RV dysfunction because
diastolic dysfunction in swine with type II PH was
associated with reduced SERCA2a-expression (Aguero
et al. 2014). Additional studies in our CTEPH model
are required to further investigate the post-translational
modifications in contractile and Ca2+-handling proteins.
Another key factor that distinguishes adaptive RV
remodelling from RV failure is myocardial angiogenesis
(Frump et al. 2018). Angiogenesis allows RV perfusion
to be enhanced commensurate with the increase in
RV mass. Indeed, many studies have shown that RV
failure is accompanied by a reduction in capillary density,
whereas capillary density is preserved or even increased
in adaptive RV remodelling (an overview of angiogenesis
in the RV in a variety of animal models with PH
is provided by Frump et al. 2018). Although chronic
administration of L-NAME could significantly reduce
myocardial angiogenesis (Matsunaga et al. 2002) and
limit myocardial perfusion, capillary density was actually
increased in the RV of CTEPH swine and correlated with
stroke work during exercise. These data are in accordance
with recent data obtained in another porcine CTEPH
model (Loisel et al. 2019) suggesting a state of adaptive
RV remodelling with sufficient myocardial perfusion
and oxygenation under resting conditions. Nevertheless,
VEGFA-expression was higher in swine with CTEPH
(Loisel et al. 2019; present study) and correlated with
RV–PA coupling during exercise, suggesting that, even
though expression of HIF-1α andHIF-2αwas unchanged,
therewas still a need for additional perfusionduring stress.
Indeed,myocardial perfusion reserve has been shown tobe
reduced in humans with CTEPH and PAH (van Wolferen
et al. 2008;Vogel-Claussen et al. 2011). Furthermore,myo-
cardial perfusion reserve correlated inversely with mPAP
andRVwork in these studies, suggesting thatflowreserve is
recruited as a result of the increased work (Vogel-Claussen
et al. 2011) and maximal flowmay be limited as a result of
increased extravascular compression (van Wolferen et al.
2008).
ROCK2 is not only expressed in the myocardium, but
also in the vasculature, where its expression correlates with
oxidative stress and NOX-expression (Chen et al. 2017).
NOX1, NOX2 and NOX4 were up-regulated in the right
coronary artery of swine with pulmonary artery banding,
whichwas accompaniedbyoxidative stress andendothelial
dysfunction, despite maintained eNOS expression (Lu
et al. 2011). The up-regulation of NOX1 and NOX4, as
well as the unaltered eNOS expression in theRVofCTEPH
swine, as observed in the present study, are consistent with
these data, although we did not determine the exact intra-
myocardial location of their expression. Furthermore,
up-regulation of NOX4 is also consistent with recent data
from patients with PAH, in which circulating NOX4 was
increased (He et al. 2017). Finally, the correlation ofNOX1
and NOX4 with RV–PA coupling suggests that oxidative
stress in the myocardium may contribute to worsening of
RV function.
Conclusion and clinical implications
In swine with CTEPH, the increased afterload resulted
in RV hypertrophy, which contributed to a maintained
resting RV function, although a trend towards RV
dilatation and reduced RVEF was observed with CMR.
Consistent with data obtained in CTEPH patients without
overt RV failure (Hardziyenka et al. 2011), neither LV
function, nor LV gene expression (perhaps with exception
of ROCK2, NOX2 and BCL2) were altered.
CTEPH is different from PAH in that patients often
experience an acute thromboembolic event prior to
development of the disease. This form of PH therefore
has the potential for follow-up and earlier therapeutic
interventions. Exercise unmasked mild RV dysfunction,
as indicated by reduced RV–PA coupling, which may
facilitate early diagnosis of patients at risk for developing
persistent RV failure. The present study shows that
this mild RV dysfunction correlates with changes in
expression of genes involved in oxidative stress, apoptosis
and angiogenesis. These changes in gene expression
suggest activation of an inflammatory response in the
RV, promoting oxidative stress. Given that ROCK2
shows a strong correlation with RV dysfunction and has
been shown to play a detrimental role in inflammation,
oxidative stress, interstitial fibrosis, cardiac hypertrophy
and impaired myocardial perfusion, ROCK2 inhibition
may provide a viable target for early therapeutic
intervention.
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